Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Babar Bashir

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Journal for Immunotherapy of Cancer|August 22, 2020
Chimeric Ad5.F35 vector evades anti-adenovirus serotype 5 neutralization opposing GUCY2C-targeted antitumor immunityJohn C Flickinger, Jagmohan Singh, Robert Carlson, et al.
Radiation Oncology (London, England)|May 29, 2024
Early outcomes of MR-guided SBRT for patients with recurrent pancreatic adenocarcinomaSpencer J Poiset, Sophia Shah, Louis Cappelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 4, 2024
Results From First-in-Human Phase I Dose-Escalation Study of a Novel Bicycle Toxin Conjugate Targeting EphA2 (BT5528) in Patients With Advanced Solid TumorsBabar Bashir, Judy S Wang, Gerald Falchook, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2025
IK-175, an Oral Aryl Hydrocarbon Receptor Inhibitor, Alone and with Nivolumab in Patients with Advanced Solid Tumors and Urothelial CarcinomaDavid H Aggen, Meredith McKean, Jean H Hoffman-Censits, et al.
Clinical Lung Cancer|May 14, 2024
Brief Report: Impact of Anti-Cancer Treatments on Outcomes of COVID-19 in Patients With Thoracic Cancers: A CCC19 Registry AnalysisAmit A Kulkarni, Cassandra Hennessy, Grace Wilson, et al.
JAMA Network Open|January 4, 2022
Assessment of Regional Variability in COVID-19 Outcomes Among Patients With Cancer in the United StatesJessica E Hawley, Tianyi Sun, David D Chism, et al.
Open Forum Infectious Diseases|February 24, 2022
Coinfections in Patients With Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) StudyGowri Satyanarayana, Kyle T Enriquez, Tianyi Sun, et al.
JAMA Oncology|August 17, 2023
Systemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19Shuchi Gulati, Chih-Yuan Hsu, Surbhi Shah, et al.
Blood Cancer Discovery|March 9, 2022
Patients Recently Treated for B-lymphoid Malignancies Show Increased Risk of Severe COVID-19Samuel M Rubinstein, Divaya Bhutani, Ryan C Lynch, et al.
Translational Oncology|June 11, 2023
COVID-19 severity and cardiovascular outcomes in SARS-CoV-2-infected patients with cancer and cardiovascular diseaseMelissa Y Y Moey, Cassandra Hennessy, Benjamin French, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Journal for Immunotherapy of Cancer|August 22, 2020
Chimeric Ad5.F35 vector evades anti-adenovirus serotype 5 neutralization opposing GUCY2C-targeted antitumor immunityJohn C Flickinger, Jagmohan Singh, Robert Carlson, et al.
Radiation Oncology (London, England)|May 29, 2024
Early outcomes of MR-guided SBRT for patients with recurrent pancreatic adenocarcinomaSpencer J Poiset, Sophia Shah, Louis Cappelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 4, 2024
Results From First-in-Human Phase I Dose-Escalation Study of a Novel Bicycle Toxin Conjugate Targeting EphA2 (BT5528) in Patients With Advanced Solid TumorsBabar Bashir, Judy S Wang, Gerald Falchook, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2025
IK-175, an Oral Aryl Hydrocarbon Receptor Inhibitor, Alone and with Nivolumab in Patients with Advanced Solid Tumors and Urothelial CarcinomaDavid H Aggen, Meredith McKean, Jean H Hoffman-Censits, et al.
Clinical Lung Cancer|May 14, 2024
Brief Report: Impact of Anti-Cancer Treatments on Outcomes of COVID-19 in Patients With Thoracic Cancers: A CCC19 Registry AnalysisAmit A Kulkarni, Cassandra Hennessy, Grace Wilson, et al.
JAMA Network Open|January 4, 2022
Assessment of Regional Variability in COVID-19 Outcomes Among Patients With Cancer in the United StatesJessica E Hawley, Tianyi Sun, David D Chism, et al.
Open Forum Infectious Diseases|February 24, 2022
Coinfections in Patients With Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) StudyGowri Satyanarayana, Kyle T Enriquez, Tianyi Sun, et al.
JAMA Oncology|August 17, 2023
Systemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19Shuchi Gulati, Chih-Yuan Hsu, Surbhi Shah, et al.
Blood Cancer Discovery|March 9, 2022
Patients Recently Treated for B-lymphoid Malignancies Show Increased Risk of Severe COVID-19Samuel M Rubinstein, Divaya Bhutani, Ryan C Lynch, et al.
Translational Oncology|June 11, 2023
COVID-19 severity and cardiovascular outcomes in SARS-CoV-2-infected patients with cancer and cardiovascular diseaseMelissa Y Y Moey, Cassandra Hennessy, Benjamin French, et al.
Pageof 5